Orencia Clinical study in Early rheumatoid Arthritis using New criteria(Efficacy and safety of MTX therapy and Abatacept/MTX combination therapy in early RA patients in daily clinical practice retrospective observation study.)

Orencia Clinical study in Early rheumatoid Arthritis using New criteria(Efficacy and safety of MTX therapy and Abatacept/MTX combination therapy in early RA patients in daily clinical practice retrospective observation study.) - OCEAN study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011019

Enrollment

Registered

2013-06-23

Start date

2012-12-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who give a full consent to this study 2. Rheumatoid Arthritis patients according to criteria of ACR/EULAR2010 3. Patients with RA for one year or less 4. Patients were MTX naive and biologics naive.

Exclusion criteria

Exclusion criteria: Patients who are inadequate by investigator's decision.

Design outcomes

Primary

Measure	Time frame
Proportion of patients with SDAI remission (SDAI<=3.3) at week 52	—

Secondary

Measure	Time frame
Proportion of patients with Modified Total Sharp Score: mTSS , Health Assessment Questionnaire: HAQ, Disease Activity Score:DAS28 ESR and CRP, Safety at week 52	—

Countries

Japan

Outcome results